Literature DB >> 16632510

Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.

John Simms1, Debbie L Hay, Mark Wheatley, David R Poyner.   

Abstract

Receptor activity modifying proteins (RAMPs) are a family of single-pass transmembrane proteins that dimerize with G-protein-coupled receptors. They may alter the ligand recognition properties of the receptors (particularly for the calcitonin receptor-like receptor, CLR). Very little structural information is available about RAMPs. Here, an ab initio model has been generated for the extracellular domain of RAMP1. The disulfide bond arrangement (Cys27-Cys82, Cys40-Cys72, and Cys57-Cys104) was determined by site-directed mutagenesis. The secondary structure (alpha-helices from residues 29-51, 60-80, and 87-100) was established from a consensus of predictive routines. Using these constraints, an assemblage of 25,000 structures was constructed and these were ranked using an all-atom statistical potential. The best 1000 conformations were energy minimized. The lowest scoring model was refined by molecular dynamics simulation. To validate our strategy, the same methods were applied to three proteins of known structure; PDB:1HP8, PDB:1V54 chain H (residues 21-85), and PDB:1T0P. When compared to the crystal structures, the models had root mean-square deviations of 3.8 A, 4.1 A, and 4.0 A, respectively. The model of RAMP1 suggested that Phe93, Tyr100, and Phe101 form a binding interface for CLR, whereas Trp74 and Phe92 may interact with ligands that bind to the CLR/RAMP1 heterodimer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632510      PMCID: PMC1483116          DOI: 10.1529/biophysj.106.084582

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  36 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Cascaded multiple classifiers for secondary structure prediction.

Authors:  M Ouali; R D King
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

3.  Combining local-structure, fold-recognition, and new fold methods for protein structure prediction.

Authors:  Kevin Karplus; Rachel Karchin; Jenny Draper; Jonathan Casper; Yael Mandel-Gutfreund; Mark Diekhans; Richard Hughey
Journal:  Proteins       Date:  2003

4.  3D-Jury: a simple approach to improve protein structure predictions.

Authors:  Krzysztof Ginalski; Arne Elofsson; Daniel Fischer; Leszek Rychlewski
Journal:  Bioinformatics       Date:  2003-05-22       Impact factor: 6.937

5.  Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.

Authors:  John J Mallee; Christopher A Salvatore; Beatrice LeBourdelles; Kevin R Oliver; Jenny Longmore; Kenneth S Koblan; Stefanie A Kane
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

6.  Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity.

Authors:  Kenji Kuwasako; Kazuo Kitamura; Yasuko Nagoshi; Yuan-Ning Cao; Tanenao Eto
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

7.  Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors.

Authors:  Marjorie Flahaut; Bernard C Rossier; Dmitri Firsov
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

8.  N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.

Authors:  Marjorie Flahaut; Corinne Pfister; Bernard C Rossier; Dmitri Firsov
Journal:  Biochemistry       Date:  2003-09-02       Impact factor: 3.162

9.  Novel receptor partners and function of receptor activity-modifying proteins.

Authors:  Arthur Christopoulos; George Christopoulos; Maria Morfis; Madhara Udawela; Marc Laburthe; Alain Couvineau; Kenji Kuwasako; Nanda Tilakaratne; Patrick M Sexton
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

10.  The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein.

Authors:  Sarah Steiner; Walter Born; Jan A Fischer; Roman Muff
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

View more
  6 in total

Review 1.  Structure-function relationships of the N-terminus of receptor activity-modifying proteins.

Authors:  Tao Qi; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

2.  CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice.

Authors:  Weiliang Xie; John T Fisher; Thomas J Lynch; Meihui Luo; Turan I A Evans; Traci L Neff; Weihong Zhou; Yulong Zhang; Yi Ou; Nigel W Bunnett; Andrew F Russo; Michael J Goodheart; Kalpaj R Parekh; Xiaoming Liu; John F Engelhardt
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

Review 3.  Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.

Authors:  Eric L Moore; Christopher A Salvatore
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Calcitonin gene-related peptide: physiology and pathophysiology.

Authors:  F A Russell; R King; S-J Smillie; X Kodji; S D Brain
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

5.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

6.  Dissection of functional residues in receptor activity-modifying proteins through phylogenetic and statistical analyses.

Authors:  Alfonso Benítez-Páez; Sonia Cárdenas-Brito
Journal:  Evol Bioinform Online       Date:  2008-04-28       Impact factor: 1.625

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.